Work

Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)

Year: 2010

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e3181ec1713

Authors: Gregory A. Otterson, Lydia Hodgson, Herbert Pang, Everett E. Vokes

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Duke Medical Center, University of Chicago

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: Alliance Statistics and Data Management Center, WUMC Cancer and Leukemia Group B, Cancer and Leukemia Group B Statistical Center, Cancer and Leukemia Group B, Cancer and Leukemia Group B: RPCI/SUNYAB, Cancer and Leukemia Group B, Cancer and Leukemia Group B, Delaware/Christiana Care Community Clinical Oncology Program, Cancer and Leukemia Group B, Heartland Cancer Research CCOP, Hematology-Oncology Associates of Central New York CCOP, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, Alliance for Clinical Trials in Oncology Operations Center

OpenAlex ID: W1990980777

FWCI: 3.474

Cites: 34

Cited by: 73

Related to: 10